
zzso zzso zzso are among the most common benign tumors of the central nervous zzso zzso VS are the hallmark of zzso type II, commonly leading to complete deafness and zzso nerve deficits as a result of tumor progression or treatment with surgery or zzso zzso medical therapies are needed to address tumor progression and zzso zzso This article reviews the standard therapies for zzso summarizes the molecular biology of these tumors, and describes potential targets for zzso zzso The article also defines and recommends the use of specific clinical end points in future drug trials, describes previous and current experience with zzso and zzso agents, and zzso areas of future zzso 

